Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neurology

• Publication date

  2009-04-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00415-009-5114-6PMID 19353223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of genetic variants of methionine metabolism with MTX-induced CNS white matter changes in patients with primary central nervous system lymphoma

  2009cited by this paper
• Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.

  2009cited by this paper
• Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children.

  2007cited by this paper
• X-linked adrenoleukodystrophy

  2007cited by this paper
• Homocysteine metabolism and various consequences of folate deficiency

  2006cited by this paper
• The cystathionine beta‐synthase variant c.844_845ins68 protects against CNS demyelination in X‐linked adrenoleukodystrophy

  2006cited by this paper
• Vitamin B12 and methionine synthesis: A critical review. Is nature's most beautiful cofactor misunderstood?

  2006cited by this paper
• Homocysteine and Carotid Intima-Media Thickness in a German Population: Lack of Clinical Relevance

  2006cited by this paper
• Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy

  2006cited by this paper
• Transcobalamin 776C->G polymorphism negatively affects vitamin B-12 metabolism.

  2005cited by this paper
• Mouse models and genetic modifiers in X-linked adrenoleukodystrophy.

  2003cited by this paper
• Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening

  2001cited by this paper
• Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects.

  2001cited by this paper
• Clinical and genetic aspects of X-linked adrenoleukodystrophy.

  1998cited by this paper
• Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies.

  1998cited by this paper
• Mutations in the adrenoleukodystrophy gene

  1997cited by this paper
• Reply from the Author

  1996cited by this paper
• Mutational analysis of patients with X‐linked adrenoleukodystrophy

  1995cited by this paper
• A CRITICAL REVIEW

  1939cited by this paper

• Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy

  2025cites this paper
• Childhood Cerebral Adrenoleukodystrophy: Case Report and Literature Review Advocating for Newborn Screening

  2024cites this paper
• Edgetic Perturbations Contribute to Phenotypic Variability in PEX26 Deficiency

  2021cites this paper
• Deciphering the modifiers for phenotypic variability of X-linked adrenoleukodystrophy

  2020cites this paper
• Natural history of a cohort of ABCD1 variant female carriers

  2018cites this paper
• X‐linked Adrenoleukodystrophy

  2017cites this paper
• Peroxisomal disorders: Clinical and biochemical laboratory aspects

  2017cites this paper
• Nrf2 and rip140 as new therapeutic targets for x-linked adrenoleukodystrophy (x-ald): control of redox/metabolic homeostasis and inflammation

  2017cites this paper
• Adrenoleukodystrophy – neuroendocrine pathogenesis and redefinition of natural history

  2016cites this paper
• CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids.

  2016cites this paper
• Peroxisome biogenesis in mammalian cells: The impact of genes and environment.

  2016cites this paper
• Adrenoleukodystrophy: An X-Linked Leukodystrophy With Predominent Neurological Manifestation : A Case Report

  2016cites this paper
• The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis

  2015influential citation
• Chapter 64 – Peroxisomal Disorders

  2015cites this paper
• X-linked adrenoleukodystrophy : Clinical , metabolic , genetic and pathophysiological aspects ☆

  2015cites this paper
• The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis

  2015influential citation
• Etude structure/fonction du demi-transporteur ABCD2 dans le contexte de l'Adrénoleucodystrophie liée à l'X

  2013cites this paper
• Adrenoleukodystrophy in Norway: high rate of de novo mutations and age-dependent penetrance.

  2013cites this paper
• X-linked Adrenoleukodystrophy

  2013cites this paper
• X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.

  2012cites this paper
• Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma

  2012cites this paper
• ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions.

  2011cites this paper
• ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.

  2011cites this paper
• Myelin lesions associated with lysosomal and peroxisomal disorders

  2010cites this paper
• Leukodystrophies with late disease onset: an update

  2010cites this paper
• General Aspects and Neuropathology of X‐Linked Adrenoleukodystrophy

  2009cites this paper
• The Application of Clinical Genetics Dovepress the Genetic Landscape of X-linked Adreno- Leukodystrophy: Inheritance, Mutations, Modifier Genes, and Diagnosis

  year unknowncites this paper